Drug combo slows progression in advanced breast cancer
(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth
Updated on: May 23,2024
7

Drug combo slows progression in advanced breast cancer
(HealthDay)—Treatment with a combination of alpelisib and fulvestrant prolongs progression-free survival among patients withPIK3CA-mutated, hormone receptor (HR)-positive, human epidermal growth
Updated on:May 23,2024
7
